Quick Answer
MIRA PHARMACEUTICALS, INC. reported Net Income of -$10.44 million for fiscal year 2025.
MIRA PHARMACEUTICALS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$10.44M | -33.0% |
| 2024 | -$7.85M | +34.5% |
| 2023 | -$11.98M | -69.8% |
| 2022 | -$7.06M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.14M | +44.3% | +26.0% |
| June 30, 2025 | -$1.54M | +9.1% | +13.8% |
| March 31, 2025 | -$1.78M | -3.8% | +12.7% |
| September 30, 2024 | -$2.04M | +43.0% | -20.8% |
| June 30, 2024 | -$1.69M | -33.6% | +1.5% |
| March 31, 2024 | -$1.72M | -28.1% | +52.1% |
| September 30, 2023 | -$3.59M | -98.1% | -183.4% |
| June 30, 2023 | -$1.27M | +47.7% | +5.6% |
- MIRA PHARMACEUTICALS, INC. showed a decrease of -33.0% in Net Income compared to the prior fiscal year.
- Over the 2022–2025 period, MIRA PHARMACEUTICALS, INC.’s net income has declined by 47.9% (from -$7.06 million to -$10.44 million).
- The most recent figure is from MIRA PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: